Medicare Enrolled
Tanya Kirpalani, PA-C
Chronic Disease Hospital · Clermont, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Kirpalani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Kirpalani?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Kirpalani
Tanya Kirpalani is a chronic disease hospital specialist in Clermont, FL, with 15 years of NPI registration. Based on federal Medicare data, Kirpalani performed 528 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Kirpalani received a total of $7,579 from 51 pharmaceutical and/or device companies across 410 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Kirpalani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years of NPI registration
▲ 528 Medicare services
$7,579 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Physician Assistant | 9105761 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗528
Medicare services
1.0× state median for chronic disease hospital
Not available
Unique patients (not deduplicated)
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
225 | $66 | $339 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
64 | $107 | $359 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
41 | $100 | $442 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
31 | $9 | $69 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
30 | $44 | $241 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
24 | $280 | $719 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
24 | $30 | $76 |
| Annual depression screening | 23 | $15 | $54 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
21 | $30 | $76 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
19 | $71 | $129 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
13 | $2 | $10 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
13 | $4 | $17 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$7,579
Total received (2021-2024)
Avg $1,895/year across 4 years
Top 0% in FL for chronic disease hospital
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
410
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,916
2023
$1,870
2022
$2,094
2021
$1,699
Payments by company (2024)
ABBVIE INC.
$271
AstraZeneca Pharmaceuticals LP
$245
Novo Nordisk Inc
$166
Lilly USA, LLC
$155
Bayer Healthcare Pharmaceuticals Inc.
$145
Boehringer Ingelheim Pharmaceuticals, Inc.
$96
Amgen Inc.
$90
PFIZER INC.
$89
Corium, LLC
$61
Astellas Pharma US Inc
$48
Tolmar, Inc.
$47
Axsome Therapeutics, Inc.
$46
SCILEX PHARMACEUTICALS INC.
$41
Otsuka America Pharmaceutical, Inc.
$39
Tris Pharma Inc
$39
Abbott Laboratories
$38
Phathom Pharmaceuticals, Inc.
$36
GlaxoSmithKline, LLC.
$36
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$34
Dexcom, Inc.
$31
Exact Sciences Corporation
$28
Phadia US Inc.
$25
Dynavax Technologies Corporation
$24
Lundbeck LLC
$21
Antares Pharma, Inc.
$19
Esperion Therapeutics, Inc.
$16
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$15
IDORSIA PHARMACEUTICALS US INC
$14
Top 3 companies account for 35.6% of 2024 payments
All-time payments by company (2021-2024) ›
Novo Nordisk Inc
$1,003
AstraZeneca Pharmaceuticals LP
$850
ABBVIE INC.
$807
Lilly USA, LLC
$574
Abbott Laboratories
$406
Bayer Healthcare Pharmaceuticals Inc.
$395
Amgen Inc.
$374
Boehringer Ingelheim Pharmaceuticals, Inc.
$234
Janssen Pharmaceuticals, Inc
$225
AbbVie Inc.
$183
JAZZ PHARMACEUTICALS INC.
$174
PFIZER INC.
$169
Corium, LLC
$164
GlaxoSmithKline, LLC.
$150
SANOFI-AVENTIS U.S. LLC
$139
Astellas Pharma US Inc
$136
Kowa Pharmaceuticals America, Inc.
$122
Bayer HealthCare Pharmaceuticals Inc.
$114
Otsuka America Pharmaceutical, Inc.
$106
Exact Sciences Corporation
$106
Axsome Therapeutics, Inc.
$92
Novartis Pharmaceuticals Corporation
$73
Dynavax Technologies Corporation
$61
Tolmar, Inc.
$60
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$59
Tris Pharma Inc
$56
Phadia US Inc.
$53
Takeda Pharmaceuticals U.S.A., Inc.
$48
Smith+Nephew, Inc.
$46
Merck Sharp & Dohme Corporation
$46
IDORSIA PHARMACEUTICALS US INC
$45
Biohaven Pharmaceuticals, Inc.
$44
SCILEX PHARMACEUTICALS INC.
$41
Clarus Therapeutics Inc.
$40
Daiichi Sankyo Inc.
$38
Phathom Pharmaceuticals, Inc.
$36
Teva Pharmaceuticals USA, Inc.
$32
Esperion Therapeutics, Inc.
$32
Dexcom, Inc.
$31
Antares Pharma, Inc.
$30
Acerus Pharmaceuticals Corporation
$26
Lundbeck LLC
$21
Scilex Pharmaceuticals Inc.
$19
Amarin Pharma Inc.
$19
SANOFI PASTEUR INC.
$19
Biohaven Pharmaceutical Holding Company Ltd.
$15
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$15
Merck Sharp & Dohme LLC
$15
Endo Pharmaceuticals Inc.
$14
Ironshore Pharmaceuticals Inc.
$13
Genentech USA, Inc.
$8
Top 3 companies account for 35.1% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · AJOVY · AREXVY · AZSTARYS · Aimovig · Azstarys · BELSOMRA · BREZTRI · CAPLYTA · COLLAGENASE SANTYL · COLOGUARD DNA CAPTURE REAGENTS · Cologuard Collection Kit · Dexcom G6 Transmitter · Dyanavel XR · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GARDASIL 9 · Heplisav-B · INJECTAFER · ImmunoCAP · JARDIANCE · JATENZO · JORNAY PM · KRYSTEXXA · Kerendia · LEQVIO · LINZESS · Livalo · MOUNJARO · NASCOBAL · NEXLETOL · NUCALA · NURTEC ODT · Natesto · Otezla · Ozempic · PREVNAR 20 · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Rybelsus · SHINGRIX · SOLIQUA 100/33 · SPRAVATO · SUNOSI · SYNJARDY · SYNTHROID · Saxenda · Sunosi · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · UBRELVY · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Wegovy · XARELTO · XIFAXAN · XYOSTED · Xofluza · ZEPBOUND · ZTLido
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Chronic disease hospitals in nearby ZIP areas
1
County median income
$69,956
Nearest hospital to ZIP centroid (approximate)
ORLANDO HEALTH SOUTH LAKE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Kirpalani is a clinical cardiology specialist, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Kirpalani experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Kirpalani performed 225 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Kirpalani receive payments from pharmaceutical companies?
Yes. Kirpalani received a total of $7,579 from 51 companies across 410 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Kirpalani's costs compare to other chronic disease hospitals in Clermont?
Kirpalani's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Kirpalani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Chronic Disease Hospitals in Clermont
Browse chronic disease hospitals in Clermont ranked by procedure volume and transparency data.
Highest volume
Top Chronic Disease Hospitals in FL
Chronic disease hospitals ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Chronic Disease Hospitals in FL
Which FL chronic disease hospitals receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology